Psychiatry A
PANSS Brief — Positive and Negative Syndrome Scale (Abbreviated)
Abbreviated PANSS assessing positive, negative, and general psychopathology domains in schizophrenia and related disorders. Full PANSS is 30-item; this abbreviated version covers key domains.
References
- Kay SR et al. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Risperidone (Paediatric) · Atypical Antipsychotic — Autism Spectrum Disorder / Schizophrenia / Tic Disorders
- Clozapine · Atypical antipsychotic (treatment-resistant schizophrenia)
- Pimavanserin · Atypical Antipsychotic — Selective 5-HT2A Inverse Agonist (Parkinson's Disease Psychosis)
- Lumateperone · Atypical Antipsychotic — Multimodal (Schizophrenia / Bipolar Depression)
- Brexpiprazole · Atypical Antipsychotic — D2/5-HT1A Partial Agonist (Schizophrenia / Adjunct MDD)
- Droperidol · Butyrophenone antipsychotic / antiemetic
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.